2 3 amino 2 hydroxypropyl hexacosahydro 3 methoxy 26 methyl 20 27 bis methylene 11 15 18 21 24 28 triepoxy 7 9 ethano 12 15 methano 9h 15h furo 3 2 i furo 2 3 5 6 pyrano 4 3 b 1 4 dioxacyclopentacosin 5 4h one, eribulin mesylate, halaven
For the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic cancer.